SECURITIES PURCHASE AGREEMENT between CEL-SCI CORPORATION and ERGOMED plc dated as of June 29, 2020Securities Purchase Agreement • July 2nd, 2020 • Cel Sci Corp • Biological products, (no disgnostic substances) • New York
May 27, 2020 CONFIDENTIALWarrant Solicitation Agreement • July 2nd, 2020 • Cel Sci Corp • Biological products, (no disgnostic substances) • Florida
The purpose of this engagement letter (the “Warrant Solicitation Agreement” or “Agreement”)) is to set forth our agreement pursuant to which Dawson James Securities, Inc. (“Dawson”) will act as warrant solicitation agent for the solicitation (the “Solicitation”) of the exercise of outstanding warrants (the “Warrants”) issued by CEL-SCI Corporation (the “Company”). This Warrant Solicitation Agreement sets forth certain conditions and assumptions upon which the Solicitation is premised.
